According to a recent report by Inc42, Dozee, a Bengaluru-based health startup, has fired 20% of its workers in a restructuring exercise. This has come as a surprise in the sector as more and more people are trying to grasp what could have made a company make such a decision.
Dozee is a leader in the health-tech domain in the country. It specialises in developing AI-powered non-contact medical devices and is a pioneer in remote patient monitoring.
A start-up that started with a golden mission
Dozee was co-founded by Mudit Dandwate and Gaurav Parchani in 2015 with a grand vision to revolutionise the hospital industry. It started as a specialist in remote, contactless monitoring of patient vitals like heart rate, respiration, blood pressure, and temperature. Its early warning system provides timely alerts to doctors, aiding in the revelation of potential health downturns.
Dozee was born out of the founders’ desire to improve health outcomes and deliver a continuum of care. Since its inception, Dozee has been at the forefront of innovation in healthcare technology. With a mission to make “Har Bed Dozee Bed”, the startup enabled hospitals to provide accurate, continuous, reliable, and affordable healthcare that enhances patient care and improves staff convenience, which leads to improved health outcomes.
However, the COVID-19 pandemic affected its business. Reportedly, the last few months have been a rough ride for the startup. The sudden decision of the company to lay off has jolted employees, particularly the on-field and sales marketing personnel.
Relocating resources with a greater focus on HealthAI
A company spokesperson told Inc42, “As part of our growth strategy, we are reallocating resources with a greater focus on HealthAI, clinical research, and international business development. The reallocation of resources with evolving business needs is a natural part of the life cycle in the growth journey of any organisation. This has affected a very minuscule number of our total headcount.”
Targetting foreign markets to ensure profits
According to sources, the startup is now focusing on the US market. “We have also expanded our footprints in the USA, UAE, and Africa. With our path-breaking innovation in AI-powered ballistocardiography, we are well on our way to becoming a global leader in HealthAI,” the Dozee spokesperson has informed Inc42.